iPTH Collection and Cold Chain Requirements
Yes, iPTH specimens should be collected on ice and maintained in a cold chain, as PTH is significantly more stable at 4°C than at room temperature 1.
Critical Preanalytical Requirements
The stability of PTH is highly temperature-dependent, and failure to maintain proper cold chain can result in falsely low PTH values that may lead to incorrect clinical decisions:
Specimen Collection and Handling
- Immediate cooling is essential: Blood samples should be placed on ice immediately after collection 2
- EDTA plasma is the preferred specimen type: The IFCC working group specifically recommends measurement of PTH in EDTA plasma rather than serum, as PTH demonstrates superior stability in EDTA plasma 1
- Rapid separation is important: While a 2-hour delay in separation causes only modest decreases (3.8% in serum, 7.4% in plasma), immediate separation is preferable 3
Temperature-Dependent Degradation
The evidence clearly demonstrates dramatic PTH degradation at room temperature:
- Room temperature storage causes severe degradation: Serum samples stored at room temperature show PTH decreases of 45% at 2 days, 59% at 4 days, and 77% at 8 days—all clinically significant changes 3
- Refrigeration preserves stability: Both EDTA plasma and serum can be stored at 4°C for up to 8 days without clinically significant changes 3
- EDTA plasma is most stable: EDTA-K3 tubes maintain intact PTH for 8 hours at room temperature and 24 hours in refrigeration, showing only 7.0% and 7.5% changes respectively 4
Practical Implementation
For routine clinical practice:
- Use EDTA-K3 tubes as the collection vessel of choice 4
- Place specimens on ice immediately after collection 2
- Separate plasma/serum promptly (ideally within 2 hours) 3
- Transport via cold chain if analysis will be delayed
- Store at 4°C if testing cannot occur within 8 hours at room temperature 3
Common Pitfalls to Avoid
- Plain tubes and gel separator tubes (GST) show faster degradation and are not recommended for PTH preservation 4
- Room temperature transport or storage will result in clinically significant underestimation of PTH levels, potentially leading to missed diagnoses of hyperparathyroidism or undertreatment of secondary hyperparathyroidism 3
- Inconsistent handling between serial measurements can create artificial trends that do not reflect true biological changes
The clinical impact is substantial: in patients with chronic kidney disease where treatment decisions are based on specific PTH thresholds (2-9 fold increases above normal), degraded samples could lead to inappropriate withholding of therapy 1. Similarly, in normocalcemic primary hyperparathyroidism where accurate PTH measurement is crucial for diagnosis, degraded samples could result in missed diagnoses 1.